Omada Health Q1 revenue rises 42% to $78 million; raises 2026 revenue outlook
Omada Health reported first quarter 2026 revenue of $78 million, up 42% from a year earlier, and a net loss of $3 million, narrower than the $9 million loss in Q1 2025. The company raised its full-year 2026 revenue outlook to $322 million to $330 million, from $312 million to $322 million, and its adjusted EBITDA outlook to $14 million to $20 million, from $7 million to $15 million.
Key points
- Q1 2026 revenue of $78 million, up 42% year over year; total members reached 1.02 million, up 51%
- Net loss of $3 million in Q1 2026, compared with $9 million in Q1 2025; adjusted EBITDA of $1 million, compared with a $4 million loss
- 2026 revenue outlook raised to $322 million to $330 million; adjusted EBITDA outlook raised to $14 million to $20 million
- Free cash flow was negative $13.4 million in Q1 2026, compared with negative $17.4 million in Q1 2025
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.